Inozyme Pharma (NASDAQ: INZY)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Inozyme Pharma (NASDAQ: INZY) through any online brokerage.
The latest price target for Inozyme Pharma (NASDAQ: INZY) was reported by Jefferies on Thursday, May 26, 2022. The analyst firm set a price target for 5.00 expecting INZY to rise to within 12 months (a possible 7.99% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Inozyme Pharma (NASDAQ: INZY) is $4.63 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Inozyme Pharma.
Inozyme Pharma’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Inozyme Pharma.
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.